Detalhe da pesquisa
1.
Intracellular activity and in vivo efficacy in a mouse model of septic arthritis of the novel pseudopeptide Pep16 against Staphylococcus aureus clinical isolates.
JAC Antimicrob Resist
; 6(1): dlae025, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38410249
2.
Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant Escherichia coli, In Vitro and in a Murine Peritonitis Model.
Antibiotics (Basel)
; 12(1)2023 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36671282